Table of contents
The success of a cell and gene therapy medical treatment is particularly sensitive to the underlying life sciences and healthcare supply chain. The end-to-end journey from patient, back to the life sciences company, then forward to the patient is complex and made up of multiple organizations, systems, and logistical processes. This makes it critical to orchestrate the processes, systems, information, and people involved. Topics covered in this FutureLink Barcelona session include:
- The topography of the cell and gene therapy network and how it works.
- Cell journey orchestration principles from the patient back to the manufacturer.
- The systems, transactions, and information flows involved, and how digital supply chain orchestration capabilities can be applied to increase visibility, eliminate delays, and reduce risk.
Gain insights on how life sciences companies, logistics service providers, and other network members can get started in building the critical digitalized visibility and collaboration network for these emerging therapies. Watch the video now.
Featured Speakers:
Adam Volini
Principal Director, Life Sciences Supply Chain & Operations
Accenture
Graham Clark
VP Alliances and Channel Sales
TraceLink
